Toggle Navigation
Each
Pod
Each
Pod
Podcasts
Episodes
Genres
Login
Oncology Times - OncTimes Talk
Sabestomig in Non-Small Cell Lung Cancer: Bi-Specific Antibody Safe and Active
Sabestomig in Non-Small Cell Lung Cancer: Bi-Specific Antibody Safe and Active
Author
Oncology Times
Published
Thu 30 Nov 2023
Episode Link
https://traffic.libsyn.com/secure/otbroadcastsarchives/OT-POD_EP52_11092023.mp3
Share to:
